1. Home
  2. SONO vs OCS Comparison

SONO vs OCS Comparison

Compare SONO & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonos Inc.

SONO

Sonos Inc.

HOLD

Current Price

$14.27

Market Cap

1.9B

ML Signal

HOLD

Logo Oculis Holding AG Ordinary shares

OCS

Oculis Holding AG Ordinary shares

HOLD

Current Price

$26.91

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SONO
OCS
Founded
2002
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.6B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
SONO
OCS
Price
$14.27
$26.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
7
Target Price
$19.67
$41.86
AVG Volume (30 Days)
1.9M
308.0K
Earning Date
05-04-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.75
N/A
Revenue
$1,443,276,000.00
N/A
Revenue This Year
$5.04
$418.43
Revenue Next Year
$6.53
$892.34
P/E Ratio
$20.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.63
$14.00
52 Week High
$19.82
$30.68

Technical Indicators

Market Signals
Indicator
SONO
OCS
Relative Strength Index (RSI) 38.09 43.56
Support Level $10.02 $25.99
Resistance Level $16.02 $29.23
Average True Range (ATR) 0.63 1.04
MACD -0.06 -0.44
Stochastic Oscillator 2.98 2.58

Price Performance

Historical Comparison
SONO
OCS

About SONO Sonos Inc.

Sonos Inc is an audio company dedicated to elevating life through sound, offering a connected platform that brings together music, movies, stories, and conversations. Its portfolio includes home theater speakers, components, plug-in and portable speakers and headphones, known for exceptional sound, thoughtful design, ease of use and seamless access to audio content. Its partner products and other revenue categories include accessories for home integration, such as custom-designed stands, mounts, and shelving units, along with partnerships for architectural speakers and automotive sound systems, as well as licensing, advertising revenue, and subscription-based services. The company operates in the United States and other countries, with the majority of revenue coming from the United States.

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

Share on Social Networks: